Table 2 shows the baseline characteristics of the included studies
Study | Patients (n) | Age (yrs) | Men (%) | HT (%) | Ds (%) | CS (%) | DM (%) |
|---|---|---|---|---|---|---|---|
N/Ov/Ob | N/Ov/Ob | N/Ov/Ob | N/Ov/Ob | N/Ov/Ob | N/Ov/Ob | N/Ov/Ob | |
Das2011 [10] | 11780/19391/18158 | 66.0/60.0/56.3 | 61.9/75.3/69.6 | 56.9/58.5/69.3 | 43.4/49.7/55.4 | 45.0/43.1/42.1 | 14.8/19.5/35.3 |
Kang 2010 [11] | 1253/1959/483 | 64.7/59.4/56.5 | 70.9/79.5/76.4 | 39.9/47.2/54.2 | 7.0/10.4/12.7 | 60.3/64.2/66.2 | 22.5/23.5/28.7 |
Lancefield 2010 [8] | 1189/2016/1426 | 67.4/64.7/61.4 | 73.2/79.0/68.8 | 58.6/61.9/74.1 | 68.5/71.7/75.6 | 23.4/19.9/23.2 | 15.9/22.3/33.6 |
Akin 2012 [12] | 1436/2839/1531 | 66.1/65.5/63.7 | 69.8/78.5/72.1 | 75.4/84.2/91.2 | 75.9/81.0/83.5 | 26.3/21.4/20.4 | 21.5/29.2/46.9 |
Cheng 2013 [13] | 477/428/340 | 67.7/61.9/57.9 | 80.1/84.3/85.0 | 53.5/55.8/56.2 | NM | 44.0/40.4/36.5 | 36.7/36.4/32.9 |
He 2015 [14] | 489/447/81 | NM | 67.7/68.0/58.0 | 62.8/76.3/72.8 | 48.7/51.0/50.6 | 16.4/13.6/14.8 | 27.4/26.4/24.7 |
Wang 2012 [15] | 1592/3026/1465 | 60.9/58.8/56.8 | 62.7/64.7/66.4 | 58.0/60.8/70.9 | 30.3/30.9/38.1 | 44.4/42.4/40.2 | 34.6/33.5/38.4 |
Numasawa 2015 [16] | 5945/3100/635 | 69.4/65.4/59.2 | 79.3/83.5/78.7 | 70.9/80.0/84.9 | 63.9/72.9/78.4 | 33.3/38.7/44.7 | 40.0/46.4/58.6 |
Buettner 2007 [17] | 551/824/292 | 65.9/64.7/62.7 | 67.0/75.0/61.0 | 55.0/62.0/70.0 | 60.0/68.0/69.0 | 21.0/25.0/24.0 | 17.0/18.0/25.0 |
Kaneko2013 [18] | 640/417/56 | 66.8/63.2/55.2 | 81.4/87.8/92.9 | 61.3/71.7/69.6 | 56.6/66.7/71.4 | 33.4/41.7/62.5 | 33.4/35.7/48.2 |
Schenkeveld 2012 [5] | 2095/2956/1246 | 62.0/62.0/59.0 | 70.0/77.0/67.0 | 34.0/39.0/55.0 | 73.0/76.0/79.0 | 27.0/22.0/23.0 | 12.0/16.0/27.0 |
Younge2013 [19] | 354/468/197 | 63.0/63.0/60.0 | 70.0/76.0/68.0 | 32.0/28.0/25.0 | 56.0/59.0/61.0 | 35.0/42.0/54.0 | 10.0/16.0/24.0 |